European Life Sciences Key IT Deals and Initiatives Update, Q2 2022

European Life Sciences Key IT Deals and Initiatives Update, Q2 2022

This document provides IDC Health Insights’ overview of key IT deals, news, and digital initiatives in the European life sciences market in Q2 2022. This is the 16th document in a quarterly series of reports released by IDC Health Insights as it continues to provide in-depth research coverage of the European life sciences industry.

Please Note: Extended description available upon request.

Executive Snapshot
Situation Overview
Expanding Pharma Beyond the Pill, Strengthening Patient Engagement
Digital Therapeutics
Smart Drug Delivery Systems
Smart Shopping and Shipping, Pharmacy Omni-Experience
Powering Precision Diagnostics, Expanding Med Tech Innovation and Services
Digital Pathology
Expanding Med Tech Services and Innovation
Expediting R&D and Advancing Precision Medicine
Trusted Research Environments and Collaborative Research Models
AI-Based Drug Discovery and Design
Solutions for Rare Disease Trials
Digital Transformation Toward an Intelligent Life Sciences Enterprise
Accelerating Digital Transformation
Toward Pharma 4.0
Customer Engagement
Supporting Innovation Acceleration
Key Mergers and Acquisitions
Advice for the Technology Buyer
Learn More
Related Research

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings